marijuana stocks

Form 8-K for VAPOR CORP.


17-Feb-2016

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Trans

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.On February 16, 2016, Vapor Corp. (the “Company”) notified the Listing Qualifications Staff (the “Staff”) of The NASDAQ Stock Market LLC (“Nasdaq”) that it is withdrawing its request to the Nasdaq Listing Qualifications Panel (the “Panel”) for an appeal of the delisting determination made by the Staff on January 22, 2016. As a result, the Company’s shares of common stock will be suspended from The Nasdaq Capital Market at the open of business on Wednesday, February 17, 2016. Nasdaq will file a Form 25 Notification of Delisting with the Securities Exchange Commission relating to the delisting of the Company’s common stock. The official delisting of the Company’s common stock will become effective ten days thereafter.

 

Item 8.01 Other EventsOn February 17, 2016, the Company issued a press release regarding the withdrawal of its request for an Appeal before the Panel regarding the Staff’s delisting determination. A copy of the press release is included as Exhibit 99.1 to this Form 8-K.

 

Item 9.01 Financial Statements and Exhibits.(d) Exhibits

Exhibit Number Description

99.1 Press release dated February 17, 2016


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Curaleaf Holdings, Inc. (CURLF) Expands New Jersey Adult-Use Sales to Bordentown Dispensary

Curaleaf Expands New Jersey Adult-Use Sales to Bordentown Dispensary Curaleaf Holdings, Inc.…

ATTBF is in the Zone!

Abattis Announces Zoning Approval on the Experion MMPR Application VANCOUVER, B.C., Oct.…

 Tetra Bio-Pharma (TBPMF) Discusses the Potential of Their ARDS-003 Drug in the Fight Against COVID-19

Tetra Bio-Pharma Discusses the Potential of Their ARDS-003 Drug in the Fight…

MariMed, Inc. (MRMD) Announces Second Quarter 2022 Earnings Date

MariMed Announces Second Quarter 2022 Earnings Date MariMed, Inc. (“MariMed” or the…